Development and sales of therapeutically related medical devices
Employees: 11-50
Total raised: $30M
Founded date: 2005
Investors 2
| Date | Name | Website |
| - | Domain Ass... | domainvc.c... |
| 06.07.2021 | New Enterp... | nea.com |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 18.01.2012 | Series C | $10M | - |
| 09.03.2010 | Series B | $20M | - |
Mentions in press and media 7
| Date | Title | Description |
| 16.07.2013 | Synthetic cartilage implant designed to restore natural joint mechanics in osteoarthritis patients | Last year the company began a clinical study with 236 patients to see how the implant worked in the metatarsophalangeal joint of the big toe. The study will measure pain, function and safety in comparison to a joint fusion, the current stan... |
| 19.01.2012 | Carticept closes $10M round from SonoSite, others | Funding Roundup | Carticept Medical closed a $10 million financing led by existing investors Domain Associates, New Enterprise Associates and SonoSite Inc. The Alpharetta, Ga.-based company said it will use the proceeds to fund the commercial launch of its N... |
| 18.01.2012 | Carticept Medical Closes $10M Financing | Carticept Medical, Inc., an Alpharetta, Ga.-based developer of innovative products for the treatment of cartilage injuries and osteoarthritis, has completed a $10m financing round. The round was led by existing investors Domain Associates, ... |
| 18.01.2012 | Carticept Medical Closes $10M Series C | ALPHARETTA, GA, Developer of innovative products for the treatment of cartilage injuries and osteoarthritis, announced that it has completed a $10 million round of financing, led by existing investors Domain Associates, New Enterprise Ass... |
| 14.10.2011 | Breast Cancer: GE Healthcare lands FDA clearance for SenoBright system | Regulatory Roundup | GE Healthcare, a unit of General Electric Company (NYSE: GE) landed FDA 510(k) clearance for its SenoBright contrast enhanced spectral mammography for breast cancer diagnosis. Launched in 2010, the SenoBright system is already used in Franc... |
| 09.03.2010 | Carticept Medical Closes $20M Series B Financing | Carticept Medical, Inc., an Alpharetta, Ga.-based developer of innovative products for the treatment of cartilage injuries and osteoarthritis, has completed a $20m Series B financing round. New investor SonoSite, Inc. joined existing invest... |
| - | Synthetic cartilage implant designed to restore natural joint mechanics in osteoarthritis patients | With an ongoing clinical trial and a new investment, startup Cartiva Inc. is well on its way to bringing a less invasive, motion-preserving alternative to joint fusion to patients in the U.S. The Alpharetta, Georgia, company just landed a $... |